Swiss National Bank’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $22.5M | Buy |
99,000
+1,700
| +2% | +$303K | 0.01% | 649 |
|
|
2026
Q1 | $16.8M | Buy |
97,300
+200
| +0.2% | +$37.1K | 0.01% | 711 |
|
|
2025
Q4 | $19.4M | Buy |
97,100
+1,900
| +2% | +$345K | 0.01% | 675 |
|
|
2025
Q3 | $14.9M | Buy |
95,200
+1,400
| +1% | +$222K | 0.01% | 758 |
|
|
2025
Q2 | $14.2M | Sell |
93,800
-5,300
| -5% | -$707K | 0.01% | 752 |
|
|
2025
Q1 | $14.9M | Sell |
99,100
-46,800
| -32% | -$7.85M | 0.01% | 711 |
|
|
2024
Q4 | $26.9M | Sell |
145,900
-6,900
| -5% | -$1.33M | 0.02% | 568 |
|
|
2024
Q3 | $30.1M | Buy |
152,800
+700
| +0.5% | +$145K | 0.02% | 547 |
|
|
2024
Q2 | $31.4M | Sell |
152,100
-1,500
| -1% | -$340K | 0.02% | 523 |
|
|
2024
Q1 | $41.6M | Sell |
153,600
-6,700
| -4% | -$1.6M | 0.03% | 474 |
|
|
2023
Q4 | $37.9M | Sell |
160,300
-4,400
| -3% | -$865K | 0.03% | 496 |
|
|
2023
Q3 | $32.3M | Sell |
164,700
-20,200
| -11% | -$4.15M | 0.03% | 525 |
|
|
2023
Q2 | $38.9M | Sell |
184,900
-16,900
| -8% | -$3.36M | 0.03% | 508 |
|
|
2023
Q1 | $40.7M | Sell |
201,800
-4,900
| -2% | -$1.11M | 0.03% | 508 |
|
|
2022
Q4 | $45M | Sell |
206,700
-13,500
| -6% | -$2.95M | 0.03% | 475 |
|
|
2022
Q3 | $43.3M | Buy |
220,200
+1,500
| +0.7% | +$324K | 0.03% | 490 |
|
|
2022
Q2 | $46.8M | Buy |
218,700
+100
| +0% | +$24.4K | 0.03% | 486 |
|
|
2022
Q1 | $62.1M | Buy |
218,600
+27,000
| +14% | +$8.33M | 0.04% | 460 |
|
|
2021
Q4 | $72.2M | Sell |
191,600
-7,100
| -4% | -$2.76M | 0.04% | 392 |
|
|
2021
Q3 | $82M | Sell |
198,700
-6,100
| -3% | -$2.53M | 0.05% | 353 |
|
|
2021
Q2 | $75.8M | Buy |
204,800
+91,100
| +80% | +$30.4M | 0.05% | 389 |
|
|
2021
Q1 | $33M | Buy |
113,700
+1,400
| +1% | +$389K | 0.02% | 581 |
|
|
2020
Q4 | $28.1M | Buy |
112,300
+100
| +0.1% | +$23.8K | 0.02% | 597 |
|
|
2020
Q3 | $25.4M | Buy |
112,200
+1,700
| +2% | +$353K | 0.02% | 568 |
|
|
2020
Q2 | $19.3M | Buy |
110,500
+15,800
| +17% | +$2.52M | 0.02% | 604 |
|
|
2020
Q1 | $12M | Buy |
94,700
+1,300
| +1% | +$195K | 0.01% | 629 |
|
|
2019
Q4 | $14.3M | Buy |
93,400
+1,600
| +2% | +$222K | 0.01% | 655 |
|
|
2019
Q3 | $12.2M | Buy |
91,800
+2,100
| +2% | +$282K | 0.01% | 703 |
|
|
2019
Q2 | $12.7M | Buy |
89,700
+2,100
| +2% | +$285K | 0.01% | 691 |
|
|
2019
Q1 | $12.7M | Buy |
87,600
+2,700
| +3% | +$355K | 0.01% | 670 |
|
|
2018
Q4 | $9.61M | Buy |
84,900
+1,300
| +2% | +$163K | 0.01% | 693 |
|
|
2018
Q3 | $11.2M | Buy |
83,600
+800
| +1% | +$98.7K | 0.01% | 694 |
|
|
2018
Q2 | $9.29M | Hold |
82,800
| – | – | 0.01% | 757 |
|
|
2018
Q1 | $8.84M | Buy |
82,800
+1,700
| +2% | +$183K | 0.01% | 765 |
|
|
2017
Q4 | $8.88M | Buy |
81,100
+1,900
| +2% | +$207K | 0.01% | 753 |
|
|
2017
Q3 | $8.55M | Hold |
79,200
| – | – | 0.01% | 747 |
|
|
2017
Q2 | $8.01M | Buy |
79,200
+900
| +1% | +$82.8K | 0.01% | 755 |
|
|
2017
Q1 | $7.04M | Buy |
78,300
+500
| +0.6% | +$42.5K | 0.01% | 799 |
|
|
2016
Q4 | $5.93M | Buy |
77,800
+1,900
| +3% | +$144K | 0.01% | 858 |
|
|
2016
Q3 | $6.33M | Sell |
75,900
-2,200
| -3% | -$184K | 0.01% | 788 |
|
|
2016
Q2 | $6.44M | Buy |
78,100
+500
| +0.6% | +$41.2K | 0.01% | 787 |
|
|
2016
Q1 | $5.69M | Buy |
77,600
+14,400
| +23% | +$1.07M | 0.01% | 806 |
|
|
2015
Q4 | $5.08M | Hold |
63,200
| – | – | 0.01% | 783 |
|
|
2015
Q3 | $4.01M | Buy |
63,200
+8,000
| +14% | +$574K | 0.01% | 889 |
|
|
2015
Q2 | $3.88M | Buy |
55,200
+1,300
| +2% | +$96.2K | 0.01% | 900 |
|
|
2015
Q1 | $4.27M | Buy |
53,900
+400
| +0.7% | +$29.5K | 0.01% | 853 |
|
|
2014
Q4 | $3.4M | Hold |
53,500
| – | – | 0.01% | 932 |
|
|
2014
Q3 | $3.2M | Sell |
53,500
-300
| -0.6% | -$17.2K | 0.01% | 937 |
|
|
2014
Q2 | $2.88M | Sell |
53,800
-600
| -1% | -$32.9K | 0.01% | 1032 |
|
|
2014
Q1 | $3.28M | Buy |
54,400
+11,300
| +26% | +$659K | 0.01% | 921 |
|
|
2013
Q4 | $2.29M | Buy |
43,100
+300
| +0.7% | +$15.1K | 0.01% | 993 |
|
|
2013
Q3 | $1.98M | Sell |
42,800
-1,800
| -4% | -$82.6K | 0.01% | 1016 |
|
|
2013
Q2 | $1.83M | Buy |
+44,600
| New | +$1.91M | 0.01% | 1036 |
|
Other funds holding CRL
AI
Swiss National Bank's CRL Position: Q2 2026 in Review
Swiss National Bank increased its Charles River Laboratories (CRL) stake by 1.7% in Q2 2026, buying an estimated $303K and bringing the position to 99,000 shares worth $22.5M. The position accounts for 0.01% of the portfolio, ranked #649.
Swiss National Bank first reported a position in CRL in Q2 2013 and has held it in 53 quarters since. The position peaked at $82M in Q3 2021. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- Swiss National Bank held 99,000 shares of Charles River Laboratories worth $22.5M as of Q2 2026.
- Swiss National Bank bought 1,700 Charles River Laboratories shares in Q2 2026, an estimated $303K.
- Charles River Laboratories made up 0.01% of Swiss National Bank's portfolio in Q2 2026, its #649 holding.
- Swiss National Bank first reported a position in Charles River Laboratories in Q2 2013 and has held it in 53 quarters since.
- Swiss National Bank's Charles River Laboratories position peaked at $82M in Q3 2021.
- 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.